SOD1 and Parkinson disease: Interestingly, oxidized wild-type SOD1 recapitulates the same toxic behavior, pinpointing the possible common pathogenic mechanism and, thus, potential therapeutic targets between mutated SOD1-related fALS and sporadic disorders exhibiting oxidized wild-type SOD1, including sporadic ALS and Alzheimer’s and Parkinson’s diseases [163].